blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2349311

EP2349311 - COMPOSITIONS AND METHODS FOR TREATMENT OF RADIATION EXPOSURE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  27.06.2014
Database last updated on 31.08.2024
Most recent event   Tooltip24.07.2015Lapse of the patent in a contracting state
New state(s): BG, HU, LU		published on 26.08.2015  [2015/35]
Applicant(s)For all designated states
Innate Immunotherapeutics Limited
4B Walls Road Penrose
Auckland 1061 / NZ
[2013/40]
Former [2011/31]For all designated states
Innate Therapeutics Limited
4B Walls Road Penrose
Auckland 1061 / NZ
Inventor(s)01 / GELDER, Frank, B.
PO Box 54015 The Marina
Auckland 2144 / NZ
02 / WEBSTER, Gillian, Alison
416a Scenic Drive
Waiatarua
Auckland / NZ
 [2013/34]
Former [2011/31]01 / GELDER, Frank, B.
PO Box 54015 The Marina
Auckland 2144 / NZ
02 / WEBSTER, Gillian, Alison
416a Scenic Drive Waiatarua
Auckland / NZ
Representative(s)Brann AB
P.O. Box 3690
Sveavägen 63
103 59 Stockholm / SE
[N/P]
Former [2013/46]Brann AB
P.O. Box 12246
102 26 Stockholm / SE
Former [2013/34]Rystedt, Per Hampus
BRANN AB
P.O. Box 12246
102 26 Stockholm / SE
Former [2011/31]Rystedt, Per Hampus
BRANN AB Uppsala Office Box 17192
10462 Stockholm / SE
Application number, filing date09818038.330.09.2009
[2011/31]
WO2009NZ00207
Priority number, dateNZ2008057166530.09.2008         Original published format: NZ 57166508
[2011/31]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2010039048
Date:08.04.2010
Language:EN
[2010/14]
Type: A1 Application with search report 
No.:EP2349311
Date:03.08.2011
Language:EN
The application published by WIPO in one of the EPO official languages on 08.04.2010 takes the place of the publication of the European patent application.
[2011/31]
Type: B1 Patent specification 
No.:EP2349311
Date:21.08.2013
Language:EN
[2013/34]
Search report(s)International search report - published on:AU08.04.2010
(Supplementary) European search report - dispatched on:EP06.06.2012
ClassificationIPC:A61K38/05, A61K45/06, A61N5/10, A61P37/04, A61P39/00
[2012/27]
CPC:
A61K38/05 (EP,US); A61K45/06 (EP,US); A61P19/00 (EP);
A61P19/08 (EP); A61P37/00 (EP); A61P37/04 (EP);
A61P39/00 (EP); A61P43/00 (EP); A61P7/00 (EP);
A61P7/04 (EP); A61P7/06 (EP); A61N2005/1094 (EP,US);
A61N2005/1098 (EP,US); A61N5/10 (EP,US) (-)
C-Set:
A61K38/05, A61K2300/00 (EP,US)
Former IPC [2011/31]A61K38/05, A61K9/14, A61P37/04, A61P39/00
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2011/31]
Extension statesALNot yet paid
BANot yet paid
RSNot yet paid
TitleGerman:ZUSAMMENSETZUNGEN UND VERFAHREN ZUR BEHANDLUNG VON STRAHLUNGSBELASTUNG[2011/31]
English:COMPOSITIONS AND METHODS FOR TREATMENT OF RADIATION EXPOSURE[2011/31]
French:COMPOSITIONS ET MÉTHODES POUR LE TRAITEMENT D'UNE EXPOSITION À DES RAYONNEMENTS[2013/15]
Former [2011/31]COMPOSITIONS ET MÉTHODES POUR LE TRAITEMENT D UNE EXPOSITION À DES RAYONNEMENTS
Entry into regional phase27.04.2011National basic fee paid 
27.04.2011Search fee paid 
27.04.2011Designation fee(s) paid 
27.04.2011Examination fee paid 
Examination procedure27.04.2011Examination requested  [2011/31]
21.12.2012Amendment by applicant (claims and/or description)
12.03.2013Communication of intention to grant the patent
09.07.2013Fee for grant paid
09.07.2013Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  12.03.2013
Opposition(s)22.05.2014No opposition filed within time limit [2014/31]
Fees paidRenewal fee
21.09.2011Renewal fee patent year 03
24.09.2012Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU30.09.2009
AT21.08.2013
BE21.08.2013
BG21.08.2013
CY21.08.2013
CZ21.08.2013
DK21.08.2013
EE21.08.2013
FI21.08.2013
HR21.08.2013
LT21.08.2013
LV21.08.2013
MC21.08.2013
MK21.08.2013
MT21.08.2013
NL21.08.2013
PL21.08.2013
RO21.08.2013
SE21.08.2013
SI21.08.2013
SK21.08.2013
SM21.08.2013
TR21.08.2013
CH30.09.2013
IE30.09.2013
LI30.09.2013
LU30.09.2013
NO21.11.2013
GR22.11.2013
IS21.12.2013
PT23.12.2013
[2015/34]
Former [2015/32]AT21.08.2013
BE21.08.2013
CY21.08.2013
CZ21.08.2013
DK21.08.2013
EE21.08.2013
FI21.08.2013
HR21.08.2013
LT21.08.2013
LV21.08.2013
MC21.08.2013
MK21.08.2013
MT21.08.2013
NL21.08.2013
PL21.08.2013
RO21.08.2013
SE21.08.2013
SI21.08.2013
SK21.08.2013
SM21.08.2013
TR21.08.2013
CH30.09.2013
IE30.09.2013
LI30.09.2013
NO21.11.2013
GR22.11.2013
IS21.12.2013
PT23.12.2013
Former [2015/24]AT21.08.2013
BE21.08.2013
CY21.08.2013
CZ21.08.2013
DK21.08.2013
EE21.08.2013
FI21.08.2013
HR21.08.2013
LT21.08.2013
LV21.08.2013
MC21.08.2013
NL21.08.2013
PL21.08.2013
RO21.08.2013
SE21.08.2013
SI21.08.2013
SK21.08.2013
SM21.08.2013
CH30.09.2013
IE30.09.2013
LI30.09.2013
NO21.11.2013
GR22.11.2013
IS21.12.2013
PT23.12.2013
Former [2014/34]AT21.08.2013
BE21.08.2013
CY21.08.2013
CZ21.08.2013
DK21.08.2013
EE21.08.2013
FI21.08.2013
HR21.08.2013
LT21.08.2013
LV21.08.2013
MC21.08.2013
NL21.08.2013
PL21.08.2013
RO21.08.2013
SE21.08.2013
SI21.08.2013
SK21.08.2013
CH30.09.2013
IE30.09.2013
LI30.09.2013
NO21.11.2013
GR22.11.2013
IS21.12.2013
PT23.12.2013
Former [2014/33]AT21.08.2013
BE21.08.2013
CY21.08.2013
CZ21.08.2013
DK21.08.2013
EE21.08.2013
FI21.08.2013
HR21.08.2013
LT21.08.2013
LV21.08.2013
MC21.08.2013
NL21.08.2013
PL21.08.2013
RO21.08.2013
SE21.08.2013
SI21.08.2013
SK21.08.2013
IE30.09.2013
NO21.11.2013
GR22.11.2013
IS21.12.2013
PT23.12.2013
Former [2014/25]AT21.08.2013
BE21.08.2013
CY21.08.2013
CZ21.08.2013
DK21.08.2013
EE21.08.2013
FI21.08.2013
HR21.08.2013
LT21.08.2013
LV21.08.2013
MC21.08.2013
NL21.08.2013
PL21.08.2013
RO21.08.2013
SE21.08.2013
SI21.08.2013
SK21.08.2013
NO21.11.2013
GR22.11.2013
IS21.12.2013
PT23.12.2013
Former [2014/23]AT21.08.2013
BE21.08.2013
CY21.08.2013
CZ21.08.2013
DK21.08.2013
EE21.08.2013
FI21.08.2013
HR21.08.2013
LT21.08.2013
LV21.08.2013
NL21.08.2013
PL21.08.2013
RO21.08.2013
SE21.08.2013
SI21.08.2013
SK21.08.2013
NO21.11.2013
GR22.11.2013
IS21.12.2013
PT23.12.2013
Former [2014/22]AT21.08.2013
BE21.08.2013
CY21.08.2013
DK21.08.2013
FI21.08.2013
HR21.08.2013
LT21.08.2013
LV21.08.2013
NL21.08.2013
PL21.08.2013
RO21.08.2013
SE21.08.2013
SI21.08.2013
NO21.11.2013
GR22.11.2013
IS21.12.2013
PT23.12.2013
Former [2014/21]AT21.08.2013
BE21.08.2013
CY21.08.2013
DK21.08.2013
FI21.08.2013
HR21.08.2013
LT21.08.2013
LV21.08.2013
PL21.08.2013
SE21.08.2013
SI21.08.2013
NO21.11.2013
GR22.11.2013
IS21.12.2013
PT23.12.2013
Former [2014/18]AT21.08.2013
BE21.08.2013
CY21.08.2013
FI21.08.2013
HR21.08.2013
LT21.08.2013
LV21.08.2013
PL21.08.2013
SE21.08.2013
SI21.08.2013
NO21.11.2013
GR22.11.2013
IS21.12.2013
PT23.12.2013
Former [2014/14]CY26.06.2013
AT21.08.2013
BE21.08.2013
FI21.08.2013
HR21.08.2013
LT21.08.2013
LV21.08.2013
PL21.08.2013
SE21.08.2013
SI21.08.2013
NO21.11.2013
GR22.11.2013
IS21.12.2013
PT23.12.2013
Former [2014/12]CY26.06.2013
AT21.08.2013
FI21.08.2013
HR21.08.2013
LT21.08.2013
LV21.08.2013
PL21.08.2013
SE21.08.2013
SI21.08.2013
NO21.11.2013
GR22.11.2013
IS21.12.2013
PT23.12.2013
Former [2014/11]CY26.06.2013
AT21.08.2013
FI21.08.2013
HR21.08.2013
LT21.08.2013
PL21.08.2013
SE21.08.2013
NO21.11.2013
IS21.12.2013
PT23.12.2013
Former [2014/10]CY26.06.2013
AT21.08.2013
HR21.08.2013
LT21.08.2013
SE21.08.2013
NO21.11.2013
IS21.12.2013
PT23.12.2013
Former [2014/09]AT21.08.2013
HR21.08.2013
LT21.08.2013
SE21.08.2013
NO21.11.2013
PT23.12.2013
Former [2014/08]LT21.08.2013
NO21.11.2013
PT23.12.2013
Former [2014/07]NO21.11.2013
Documents cited:Search[I]SE8803621  ;
 [X]  - PURI N ET AL, "Adjuvancy enhancement of muramyl dipeptide by modulating its release from a physicochemically modified matrix of ovalbumin microspheres - I. In vitro characterization", JOURNAL OF CONTROLLED RELEASE, ELSEVIER, AMSTERDAM, NL, (20001003), vol. 69, no. 1, doi:10.1016/S0168-3659(00)00289-3, ISSN 0168-3659, pages 53 - 67, XP004217534 [X] 1-15 * abstract *

DOI:   http://dx.doi.org/10.1016/S0168-3659(00)00289-3
 [X]  - YOUAN B B C ET AL, "PROTEIN-LOADED POLY(EPSILON-CAPROLACTONE) MICROPARTICLES.II. MURAMYL DIPEPTIDE FOR ORAL CONTROLLED RELEASE OF ADJUVANT", JOURNAL OF MICROENCAPSULATION, TAYLOR AND FRANCIS, BASINGSTOKE, GB, (19990901), vol. 16, no. 5, doi:10.1080/026520499288799, ISSN 0265-2048, pages 601 - 612, XP000834852 [X] 1-15 * abstract *

DOI:   http://dx.doi.org/10.1080/026520499288799
 [X]  - TABATA Y ET AL, "Activation of macrophage in vitro to acquire antitumor activity by a muramyl dipeptide derivative encapsulated in microspheres composed of lactide copolymer", JOURNAL OF CONTROLLED RELEASE, ELSEVIER, AMSTERDAM, NL, vol. 6, no. 1, doi:10.1016/0168-3659(87)90076-9, ISSN 0168-3659, (19871201), pages 189 - 204, (19871201), XP025929945 [X] 1-15 * abstract *

DOI:   http://dx.doi.org/10.1016/0168-3659(87)90076-9
 [X]  - PURI N ET AL, "An investigation of the intradermal route as an effective means of immunization for microparticulate vaccine delivery systems", VACCINE, ELSEVIER LTD, GB, (20000501), vol. 18, no. 23, doi:10.1016/S0264-410X(99)00440-5, ISSN 0264-410X, pages 2600 - 2612, XP004195925 [X] 1-15 * abstract *

DOI:   http://dx.doi.org/10.1016/S0264-410X(99)00440-5
 [I]  - DATABASE WPI, 0, Derwent World Patents Index, vol. 1990, no. 23, Database accession no. 1990-229805, XP002676259 & SE8803621 A 19900413 (CARBOMATRIX AB) [I] 1-15 * abstract *
 [I]  - TURANEK JAROSLAV ET AL, "Stimulation of haemopoiesis and protection of mice against radiation injury by synthetic analogues of muramyldipeptide incorporated in liposomes", INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, (199709), vol. 19, no. 9-10, ISSN 0192-0561, pages 611 - 617, XP002676260 [I] 1-15 * abstract *

DOI:   http://dx.doi.org/10.1016/S0192-0561(98)00003-4
 [Y]  - TSUBURA E ET AL, "RESTORATIVE ACTIVITY OF MUROCTASIN ON LEUKOPENIA ASSOCIATED WITH ANTICANCER TREATMENT", ARZNEIMITTEL FORSCHUNG. DRUG RESEARCH, ECV EDITIO CANTOR VERLAG, AULENDORF, DE, (19880101), vol. 38, no. 7A, ISSN 0004-4172, pages 1070 - 1074, XP001526179 [Y] 1-15 * abstract *
 [Y]  - ICHIRO AZUMA, "Review: Inducer of cytokines in vivo: Overview of field and romurtide experience", INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, ELMSFORD,NY, US, vol. 14, no. 3, doi:10.1016/0192-0561(92)90180-S, ISSN 0192-0561, (19920401), pages 487 - 496, (19920401), XP023812666 [Y] 1-15 * abstract *

DOI:   http://dx.doi.org/10.1016/0192-0561(92)90180-S
 [Y]  - KAWAMORI J ET AL, "[Effectiveness of thrice-weekly injection of romurutide for prophylaxis of leukocytopenia during radiation therapy].", MEDLINE, US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US, (199406), Database accession no. NLM8002621, XP002676292 [Y] 1-15 * abstract *
    [ ] - GAN TO KAGAKU RYOHO. CANCER & CHEMOTHERAPY JUN 1994 LNKD- PUBMED:8002621, (199406), vol. 21, no. 7, ISSN 0385-0684, pages 1057 - 1062
 [Y]  - NAMBA KENJI ET AL, "Enhancement of platelet recovery in X-irradiated guinea pigs by romurtide, a synthetic muramyl dipeptide derivative", BLOOD, AMERICAN SOCIETY OF HEMATOLOGY, US, (19940501), vol. 83, no. 9, ISSN 0006-4971, pages 2480 - 2488, XP009159439 [Y] 1-15 * abstract * * page 2480, column 1 *
 [Y]  - YOUAN B B C ET AL, "Poly(epsilon-caprolactone) microparticles containing muramyl dipeptide for oral controlled release of adjuvant", JOURNAL OF CONTROLLED RELEASE, ELSEVIER, AMSTERDAM, NL, (19971013), vol. 48, no. 2-3, ISSN 0168-3659, page 339, XP009128125 [Y] 1-15 * abstract *
 [Y]  - MORIN C ET AL, "Improved intracellular delivery of a muramyl dipeptide analog by means of nanocapsules", INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, ELMSFORD,NY, US, vol. 16, no. 5-6, doi:10.1016/0192-0561(94)90035-3, ISSN 0192-0561, (19940501), pages 451 - 456, (19940501), XP023811800 [Y] 1-15 * abstract *

DOI:   http://dx.doi.org/10.1016/0192-0561(94)90035-3
International search[X]WO9815658  (PROBE INTERNATIONAL [US]);
 [Y]  - AZUMA, "Synthetic Immunoadjuvants: Application to Non-Specific Host Stimulation and Potentiation of Vaccine Immunogenicity", VACCINE, (1992), vol. 10, no. 14, pages 1000 - 1006, XP002415636

DOI:   http://dx.doi.org/10.1016/0264-410X(92)90108-V
 [Y]  - MASIHI ET AL., "Muramyl Dipeptide Inhibits Replication of Human Immunodeficiency I Virus in Vitro", AIDS RESEARCH AND HUMAN RETROVIRUSES, (1990), vol. 6, no. 3, pages 393 - 399, XP008146898
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.